Spero Therapeutics logo
VerifiedBiotechnology Research· Founded 2013

Spero Therapeutics

We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant ("MDR”) bacterial infections with high unmet need. Our pipeline consists of three mid to late-stage clinical assets. Tebipenem HBr is in Phase 3 development, with the potential to be the first broad-spectrum oral carbapenem to treat complicated urinary tract infections ("cUTIs”) including acute pyelonephritis, caused by certain microorganisms, in adult patients. SPR206 is a Phase 2 ready IV-administered antibiotic being developed as an innovative option to treat MDR Gram-negative bacterial infections in the hospital setting. SPR720, the development of which was recently suspended, is a Phase 2 investigational oral agent for the first-line treatment of nontuberculous mycobacterial ("NTM”) pulmonary disease, a rare disease. As previously disclosed, following the SPR720 program suspension, we are evaluating other potential paths forward as the remaining data are collected and analyzed.

7-day free trial · no credit card

HeadquartersCambridge, United StatesEmployees48(11 to 50)Annual revenue$50M to <$100MFounded year2013Websitesperotherapeutics.comLinkedIn profileLinkedIn

Verified contacts

44

available on Kipplo

LinkedIn employees

48

11 to 50 range

Open roles

no listings

Distinct roles

31

indexed titles

Tech stack

5

tools in use

Monthly traffic

731

organic / mo

Sign up free to see all 44 verified contacts at Spero Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

44 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Spero Therapeutics

31 distinct titles indexed · top 10 shown.

  • 2()
  • 2board member
  • 2qa consultant
  • 1,,
  • 1associate director, fp & a
  • 1associate director, quality assurance
  • 1chief operating officer, spero therapeutics
  • 1executive director
  • 1executive director, head of clinical pharmacology, dmpk and drug analysis
  • 1icon plc
  • +21more titles

Sign up to unlock all 44 contacts at Spero Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 44 verified contacts at Spero Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Spero Therapeutics | Kipplo Discover